Randomized Controlled Trial of an Incentive-based Physical Activity Program Targeting Both Children and Adults (FIT-FAM) (FIT-FAM)
perjantai 6. heinäkuuta 2018 päivittänyt: Eric A. Finkelstein, Duke-NUS Graduate Medical School
This study aims to test whether incentives can motivate children to promote increased physical activity of a working parent while also increasing their own activity levels.
Tutkimuksen yleiskatsaus
Yksityiskohtainen kuvaus
There is overwhelming evidence that sustained physical activity reduces the risk of many common diseases. Yet, data reveal low levels of physical activity among working age adults and their children in Singapore. One strategy that has been successfully employed to influence behaviours of parents is to use their children as an intermediary. This strategy has a successful track record in public health, where children have helped their parents quit smoking and wear seatbelts.
In this study, the investigators propose to test whether children can promote increased physical activity of a working parent at the same time that they increase their own activity level. This proposal is an extension of a prior study where the investigators showed that modest financial incentives can increase physical activity levels among children. The investigators now propose to conduct a follow-on trial where the reward is tied not only to the child's own steps, but to that of a parent. Rewards will be based on step activity measured through a state-of-the-art wireless step counter worn on the wrist or hip. Just as children were motivated to increase their own activity levels in efforts to achieve the incentive, the investigators hypothesize that they will also be effective advocates for increasing the activity levels of their parents.
Specifically, the investigators propose to conduct a 12 month two-arm randomized controlled trial (RCT) to evaluate the efficacy of the family based incentive scheme on working parents' physical activity as measured via accelerometry. The investigators hypothesize that parents in the family-based incentive arm (FBI) will show a greater number of daily steps at the interim 6 month assessment and the final 12 month assessment point compared to parents in the child based incentive (CBI) arm, as measured by accelerometry. Secondary aims test the effects of the intervention on parent's and child's MVPA bout minutes per week, MVPA minutes, and other physical activity endpoints measured by accelerometry, child's steps, parent's and child's activity levels throughout the intervention period measured by the pedometer, and on health outcomes and health-related quality of life of parents at follow-up.
Opintotyyppi
Interventio
Ilmoittautuminen (Todellinen)
644
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.
Opiskelupaikat
-
-
-
Singapore, Singapore, 169857
- Duke-NUS Medical School
-
-
Osallistumiskriteerit
Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.
Kelpoisuusvaatimukset
Opintokelpoiset iät
7 vuotta - 65 vuotta (Lapsi, Aikuinen, Vanhempi Aikuinen)
Hyväksyy terveitä vapaaehtoisia
Joo
Sukupuolet, jotka voivat opiskella
Kaikki
Kuvaus
Inclusion Criteria:
- Child must be aged 7 - 11 years
- Parent must be aged 25 - 65 years
- Parent must be full-time employee at the time of enrolment
- Parent should be Singaporean citizen or permanent resident
- Parent and child must provide at least 4 valid days of accelerometer data (3 weekday days and 1 weekend day of at least 10 hours of wear time each day)
Exclusion Criteria:
- Difficulty walking up 10 stairs without stopping (for parents)
- Having any medical condition that may limit their ability to walk as a means of physical activity (for parents)
- Pregnant (for parents)
- Are unwilling to wear a wireless pedometer for 12 months (for parents and children)
- Are unwilling to wear an accelerometer for 1 week at baseline, month 6, and month 12 assessments (for parents and children)
Conditional Eligibility Criteria:
If parents meet the following criteria, they will be required to provide an approval note from a physician to be able to participate in the study-
- Self-reported medical conditions such as hypertension or diabetes that limit the ability to walk
- Answer 'YES' to any Physical Activity Readiness (PAR-Q) question
- Family history of heart conditions
- BMI>40kg/m2
- Children on whose behalf parents answer 'YES' to any PAR-Q question will be permitted to enrol only if they provide written approval from a medical doctor
Opintosuunnitelma
Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Terveyspalvelututkimus
- Jako: Satunnaistettu
- Inventiomalli: Tehtävätehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Active Comparator: Child-based Incentive (CBI)
Children earn rewards each week (with the week beginning on Monday and ending on Sunday) that they log 10,000 daily steps on the Fitbit according to the schedule below and their matched parent logs at least 2,000 steps on ≥4 of 7 days each week (regardless of which 4 of the 7 days they wear it). Incentives are tied, in addition to child's activity, to parent's Fitbit wear so that the investigators are better able to capture parent's activity in this arm. Step Targets for Children in CBI arm:
|
Fitbit-laitteet ovat langattomia askelmittareita, jotka seuraavat osallistujien askeleita, ja niitä tarjotaan yhdessä räätälöidyn verkkosivuston kanssa, joka sisältää räätälöityjä tietoja osallistujille.
Muut nimet:
Incentives will be awarded to participating children for meeting step targets as measured by the Fitbit pedometer.
Muut nimet:
|
|
Kokeellinen: Family-based Incentive (FBI)
Children earn rewards each week that they log daily steps on the Fitbit according to the schedule below but only if their matched parent also logs 10,000 steps according to the schedule below. Otherwise, children earn no incentive for that week. Step targets for children and parents in FBI arm:
|
Fitbit-laitteet ovat langattomia askelmittareita, jotka seuraavat osallistujien askeleita, ja niitä tarjotaan yhdessä räätälöidyn verkkosivuston kanssa, joka sisältää räätälöityjä tietoja osallistujille.
Muut nimet:
Incentives will be awarded to participating children for meeting step targets as measured by the Fitbit pedometer.
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Changes in step count of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Step counts of parents will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Changes in step count of children from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Step counts of children will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in moderate to vigorous physical activity (MVPA) bout minutes of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
MVPA will be assessed via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, 6 months, and 12 months.
MVPA bout minutes are defined as a total of 10 or more consecutive minutes above the vector magnitude cutoff point of 2690 counts per min, with allowance for interruptions of 1-2 min at a magnitude less than the cutoff point.
|
Baseline, 6 months and 12 months
|
|
Changes in moderate to vigorous physical activity (MVPA) bout minutes of children from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
MVPA will be assessed via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, 6 months, and 12 months.
MVPA bout minutes are defined as a total of 10 or more consecutive minutes above the vector magnitude cutoff point of 2690 counts per min, with allowance for interruptions of 1-2 min at a magnitude less than the cutoff point.
|
Baseline, 6 months and 12 months
|
|
Changes in moderate to vigorous physical activity (MVPA) minutes of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Total MVPA minutes (including those not in bouts of 10 minutes) during each assessment period at baseline, month 6, and month 12.
This will be assessed via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day).
|
Baseline, 6 months and 12 months
|
|
Changes in moderate to vigorous physical activity (MVPA) minutes of children from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Total MVPA minutes (including those not in bouts of 10 minutes) during each assessment period at baseline, month 6, and month 12.
This will be assessed via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day).
|
Baseline, 6 months and 12 months
|
|
Changes in total volume of physical activity of parents from baseline to month 6 and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily volume of physical activity will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in total volume of physical activity of children from baseline to month 6 and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily volume of physical activity will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in sedentary behaviour of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily minutes of sedentary behaviour will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in sedentary behaviour of children from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily minutes of sedentary behaviour will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in light minutes of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily light minutes will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in light minutes of children from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily light minutes will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in total moderate minutes of parents from baseline to month 6 and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily moderate minutes will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in total moderate minutes of children from baseline to month 6 and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily moderate minutes will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in total vigorous minutes of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily vigorous minutes will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in total vigorous minutes of children from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Average daily vigorous minutes will be measured via the ActiGraph GT-3X+ accelerometer worn for a one-week period (with a minimum of 3 weekday days and 1 weekend day of at least 10 hours of wear time each day) at baseline, month 6, and month 12.
|
Baseline, 6 months and 12 months
|
|
Changes in daily average steps of parents over the 12 month study duration.
Aikaikkuna: Daily from months 1 - 12
|
Daily average steps will be calculated based on data captured by the Fitbit wireless pedometer.
|
Daily from months 1 - 12
|
|
Changes in daily average steps of children over the 12 month study duration.
Aikaikkuna: Daily from months 1 - 12
|
Daily average steps will be calculated based on data captured by the Fitbit wireless pedometer.
|
Daily from months 1 - 12
|
|
Changes in percentage of parents meeting weekly step targets over the 12 month study duration.
Aikaikkuna: Daily from months 1 - 12
|
Percentage meeting weekly step targets will be calculated based on data captured by the Fitbit wireless pedometer.
|
Daily from months 1 - 12
|
|
Changes in percentage of children meeting weekly step targets over the 12 month study duration.
Aikaikkuna: Daily from months 1 - 12
|
Percentage meeting weekly step targets will be calculated based on data captured by the Fitbit wireless pedometer.
|
Daily from months 1 - 12
|
|
Changes in percentage of parent-child dyads meeting weekly step targets over the 12 month study duration.
Aikaikkuna: Daily from months 1 - 12
|
Percentage meeting weekly step targets will be calculated based on data captured by the Fitbit wireless pedometer.
|
Daily from months 1 - 12
|
|
Change in weight of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Weight of parents will be measured at baseline, month 6, and month 12, and the difference will be calculated.
|
Baseline, 6 months and 12 months
|
|
Change in systolic blood pressure of parents from baseline to month 6 and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
Systolic blood pressure of parents will be measured at baseline, month 6, and month 12, and the difference will be calculated.
|
Baseline, 6 months and 12 months
|
|
Change in cardiorespiratory fitness of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, 6 months and 12 months
|
VO2max of parents will be measured at baseline, month 6, and month 12, and the difference will be calculated.
|
Baseline, 6 months and 12 months
|
|
Change in health-related quality of life of parents from baseline to month 6, and month 12.
Aikaikkuna: Baseline, months and 12 months
|
Health-related quality of life of parents at baseline, month 6, and month 12 will be measured via the EQ-5D-5L questionnaire.
|
Baseline, months and 12 months
|
Yhteistyökumppanit ja tutkijat
Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.
Sponsori
Julkaisuja ja hyödyllisiä linkkejä
Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.
Opintojen ennätyspäivät
Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan julkisella verkkosivustolla.
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Keskiviikko 25. marraskuuta 2015
Ensisijainen valmistuminen (Todellinen)
Maanantai 28. toukokuuta 2018
Opintojen valmistuminen (Todellinen)
Sunnuntai 3. kesäkuuta 2018
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Maanantai 27. huhtikuuta 2015
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Maanantai 3. elokuuta 2015
Ensimmäinen Lähetetty (Arvio)
Keskiviikko 5. elokuuta 2015
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Tiistai 10. heinäkuuta 2018
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Perjantai 6. heinäkuuta 2018
Viimeksi vahvistettu
Sunnuntai 1. heinäkuuta 2018
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muut tutkimustunnusnumerot
- HSRG13may010
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .